These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 1656778)
21. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum. Lundberg JM; Anggård A; Fahrenkrug J Acta Physiol Scand; 1981; 113(3):329-36. PubMed ID: 7345899 [TBL] [Abstract][Full Text] [Related]
22. Vagal control of guinea pig tracheal smooth muscle: lack of involvement of VIP or nitric oxide. Watson N; Maclagan J; Barnes PJ J Appl Physiol (1985); 1993 Apr; 74(4):1964-71. PubMed ID: 8514718 [TBL] [Abstract][Full Text] [Related]
23. Role of Na(+)-K(+)-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide. Kanemura T; Tamaoki J; Chiyotani A; Takeyama K; Sakai N; Tagaya E; Konno K Res Commun Chem Pathol Pharmacol; 1993 Jan; 79(1):11-22. PubMed ID: 8381977 [TBL] [Abstract][Full Text] [Related]
24. Comparison of vasoactive intestinal peptide and isoproterenol relaxant effects in isolated cat airways. Altiere RJ; Diamond L J Appl Physiol Respir Environ Exerc Physiol; 1984 Apr; 56(4):986-92. PubMed ID: 6725078 [TBL] [Abstract][Full Text] [Related]
25. Effects of acute and long-term atropine treatment on levels, release and response to VIP and PHI in the submandibular gland of cat and rat. Dunér-Engström M; Larsson O; Fredholm BB; Lundblad L; Fahrenkrug J; Lundberg JM Acta Physiol Scand; 1992 Nov; 146(3):357-67. PubMed ID: 1336298 [TBL] [Abstract][Full Text] [Related]
26. Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle. Suzuki R; Kobayashi S Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):250-3. PubMed ID: 6826329 [TBL] [Abstract][Full Text] [Related]
27. Nitrergic prejunctional inhibition of purinergic neuromuscular transmission in the hamster proximal colon. Matsuyama H; El-Mahmoudy A; Shimizu Y; Takewaki T J Neurophysiol; 2003 May; 89(5):2346-53. PubMed ID: 12740397 [TBL] [Abstract][Full Text] [Related]
29. Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro. Liu YC; Khawaja AM; Rogers DF Br J Pharmacol; 1999 Nov; 128(6):1353-9. PubMed ID: 10578152 [TBL] [Abstract][Full Text] [Related]
30. Vagal ganglionic and nonadrenergic noncholinergic neurotransmission to the ferret lower oesophageal sphincter. Smid SD; Blackshaw LA Auton Neurosci; 2000 Dec; 86(1-2):30-6. PubMed ID: 11269922 [TBL] [Abstract][Full Text] [Related]
31. Epithelium modulates the potency of vasoactive intestinal peptide in the guinea pig. Takubo T; Banks K; Martin JG J Appl Physiol (1985); 1991 Dec; 71(6):2146-51. PubMed ID: 1778905 [TBL] [Abstract][Full Text] [Related]
32. The vagal nerves and peptides in the control of extrahepatic biliary motility. An experimental study in the cat. Dahlstrand C Acta Physiol Scand Suppl; 1990; 589():1-52. PubMed ID: 1700577 [TBL] [Abstract][Full Text] [Related]
33. Effects of vasoactive intestinal polypeptide on the response properties of cells in area 17 of the cat visual cortex. Murphy PC; Grieve KL; Sillito AM J Neurophysiol; 1993 May; 69(5):1465-74. PubMed ID: 8389825 [TBL] [Abstract][Full Text] [Related]
34. Role of VIP and substance P in NANC innervation in the longitudinal smooth muscle of the rat jejunum - influence of extrinsic denervation. Kasparek MS; Fatima J; Iqbal CW; Duenes JA; Sarr MG J Surg Res; 2007 Jul; 141(1):22-30. PubMed ID: 17512547 [TBL] [Abstract][Full Text] [Related]
36. Is peptide histidine isoleucine an inhibitory nonadrenergic noncholinergic neurotransmitter in the rat gastric fundus? D'Amato M; Currò D; Ciabattoni G; Lefebvre RA Arch Int Pharmacodyn Ther; 1990; 303():216-31. PubMed ID: 1973609 [TBL] [Abstract][Full Text] [Related]
37. Effect of apamin on release of vasoactive intestinal polypeptide (VIP) from the cat intestines. Sjöqvist A; Fahrenkrug J; Jodal M; Lundgren O Acta Physiol Scand; 1983 Sep; 119(1):69-76. PubMed ID: 6139935 [TBL] [Abstract][Full Text] [Related]
38. Immuno-affinity purification of specific antibodies against vasoactive intestinal polypeptide (VIP) on VIP (1-10)-linked polydimethylacrylamide resin. Takeyama M; Hatano M; Otaka A; Fujii N; Yajima H Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):834-7. PubMed ID: 2752498 [TBL] [Abstract][Full Text] [Related]
39. The role of passive immunization in hiv-positive patients : a case report. Veljkovic V; Metlas R; Jevtovic D; Stringer WW Chest; 2001 Aug; 120(2):662-6. PubMed ID: 11502675 [TBL] [Abstract][Full Text] [Related]
40. Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy. Veljkovic M; Dopsaj V; Dopsaj M; Branch DR; Veljkovic N; Sakarellos-Daitsiotis MM; Veljkovic V; Glisic S; Colombatti A PLoS One; 2011; 6(11):e28304. PubMed ID: 22140573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]